EDIT Description — Editas Medicine Inc

Editas Medicine is a clinical stage genome editing company focused on developing genomic medicines to treat a range of serious diseases. Co. has developed a proprietary genome editing platform based on clustered, regularly interspaced, short palindromic repeats technology and it continues to expand its capabilities. Co. is developing in vivo gene editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body, ex vivo gene-edited cell medicines, in which cells collected from a patient are edited with Co.'s technology and then administered back to that same patient, and cellular therapy medicines.

Company Name: 
Editas Medicine Inc
Number of ETFs Holding EDIT: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   EDIT Weight   EDIT Amount 
 XBI   0.84%   $52,276,841         
 VTI   0.00%   $20,457,424         
 VB   0.01%   $16,512,364         
 IWM   0.03%   $14,032,852         
 VBK   0.03%   $9,427,318         
 VXF   0.01%   $9,126,210         
 IWN   0.06%   $6,296,088         
 VHT   0.01%   $2,183,245         
 IDNA   1.32%   $1,932,077         
 VTWO   0.03%   $1,701,616         
List of all 30 ETFs holding EDIT »
Quotes delayed 20 minutes

Email EnvelopeFree EDIT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Hold (2.43 out of 4)
1st percentile
(ranked lower than approx. 99% of all stocks covered)

Analysts Forecast:
EDIT Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding EDIT | Editas Medicine Inc | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.